The new aspirin efficacy test will help doctors avoid giving patients who are prone to heart disease aspirin that could inadvertently cause a heart attack or stroke.
According to the U.S. Food and Drug Administration, the efficacy of aspirin is under questioning when it comes to the prevention of a first heart attack for those who have never experienced heart problems. A new development by researchers in the form of a test can now assist medical professionals in determining whether a patient should be on aspirin therapy.
Representing the Minneapolis Heart Institute Foundation, Michael D. Miedema stated in the journal Circulation: Cardiovascular Quality and Outcomes:
“Many heart attacks and strokes occur in individuals who do not appear to be at high risk. Individuals with known CVD (cardiovascular disease) should take a daily aspirin, but the best approach for individuals without known CVD is unclear. If we only treat high-risk individuals with aspirin, we are going to miss a substantial portion of patients who eventually suffer heart attacks.”
Researchers who developed the device say that that it will help doctors determine the efficacy of aspirin therapy with consideration of the patient’s current health condition. The device calculates the patient’s coronary artery calcium score which measures the plaque in arteries.
While health experts maintain that aspirin can help reduce the clumping action of the platelets which helps to prevent heart disease, they also state that there can be serious side-effects which the drug including internal bleeding.
Heart Disease Patients Helped by New Aspirin Efficacy Test.